Provider P44-17 New Drug-Related Prior Authorization and Quantity Limit Criteria: Opioid, Buprenorphine Concurrent Therapy Read More
Provider P16-17 Changes in Medical Policy IV-107 Hip Arthroplasty (Hip Replacement) and Hip Resurfacing Read More
Provider P34-18 Clarification to MAPD PA Requirements for Hereditary Angioedema (HAE) Medical Drugs Read More
Provider P35-17 Addition of Drug to the Substance Reduction Therapy Prior Authorization with Quantity Limit Program Read More
Provider P11-17 Pre-Admission Notification Requirement for Admissions Effective June 1, 2017 Read More
Provider P1-18 New Drugs, Aimovig (erenumab), Fremanezumab and Galcanezumab Will Require PA Read More
